Evidence map›Paper›PMID 29084209›Full record

ArticleOncogene2018

MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.

A L Schroyer, N W Stimes, W F Abi Saab, D N Chadee

Abstract read
In one paragraph

Article in Oncogene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. MLK3 promotes atherosclerosis by regulating ferroptosis in macrophages.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. NETISCE: a network-based tool for cell fate reprogramming.NPJ systems biology and applications · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

A L SchroyerDepartment of Biological Sciences, University of Toledo, Toledo, OH, USA.
N W StimesDepartment of Biological Sciences, University of Toledo, Toledo, OH, USA.
W F Abi SaabDepartment of Biological Sciences, University of Toledo, Toledo, OH, USA.
D N ChadeeDepartment of Biological Sciences, University of Toledo, Toledo, OH, USA.
University of Toledo · US

Funding

Regulation of MLK3 by oxidative stress in colon cancer cellsR15CA199164 · NCI · UNIVERSITY OF TOLEDO · PI CHADEE, DEBORAH N · 2016 to 2016
$443k
MLK4 regulation of MAPK signalingR15GM102831 · NIGMS · UNIVERSITY OF TOLEDO · PI CHADEE, DEBORAH N · 2012 to 2012
$349k
NCI NIH HHS R15 CA199164NIGMS NIH HHS R15 GM102831
6 · The paper itself

Abstract

Mixed lineage kinase 3 (MLK3) functions in migration and/or invasion of several human cancers; however, the role of MLK3 in colorectal cancer (CRC) invasion is unknown. MLK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) which activates MAPK pathways through either kinase-dependent or -independent mechanisms. Human colorectal tumors display increased levels of reactive oxygen species (ROS) or oxidative stress. ROS, such as H

Indexed as

Oxidative StressApoptosisBiomarkers, TumorCell ProliferationColorectal NeoplasmsHumansMAP Kinase Kinase KinasesMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase Kinase Kinase 11Mutagenesis, Site-DirectedMutationNeoplasm InvasivenessTumor Cells, CulturedBiomarkers, TumorMAPK1 protein, humanMAP Kinase Kinase KinasesMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase Kinase Kinase 11

Identifiers

PMID29084209
PMCPMC5823719
OpenAlexW2766092881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.